Click here to learn more and register for the next webinar in our Research Spotlight Webinar Series.
The Nancy S. Wexler Discovery Fund fosters the highest level of scientific research in the field of Huntington’s disease. This Fund was created to honor the pioneering spirit, relentless dedication and enduring optimism of Dr. Nancy Wexler, the Hereditary Disease Foundation’s President. The Fund encourages research collaborations and the recruitment of young scientists.
Dr. Osama Al-Dalahmah, recipient, 2020 Nancy S. Wexler
Young Investigator Prize
The Nancy S. Wexler Discovery Fund, established in 2020 to honor Nancy Wexler’s extraordinary contributions to Huntington’s disease research, raised over $1.4 million in its first year, thanks to the generosity of loyal friends such as you.
The Fund supports collaborative research, educational workshops, symposia and conferences, as well as the Young Investigator Prize in Nancy’s name. The first recipient of this Prize was Dr. Osama Al-Dalahmah, MD, DPhil, of Columbia University Irving Medical Center. Dr. Al-Dalahmah aims to discover ways to increase the brain’s ability to protect itself from damage in Huntington’s disease.
We launch the Nancy S. Wexler Discovery Fund 2021 with hope and determination. Your support will enable us to advance and accelerate the discovery and development of treatments and cures for HD.
We invite you to participate in the Nancy S. Wexler Discovery Fund 2021 at the gift level of your choice.
We are grateful for your partnership. Together, we will conquer this devastating disease.
To send a gift by mail, complete this form and mail to: Hereditary Disease Foundation, 601 West 168th Street, Suite 54, New York, NY 10032.
MORE ABOUT THE NANCY S. WEXLER DISCOVERY FUND
In addition to supporting scientific collaborations, educational workshops and conferences, the Nancy S. Wexler Discovery Fund also supports the Nancy S. Wexler Young Investigator Prize awarded to researchers whose work reflects the highest caliber of excellence, diligence and creative thinking. The Hereditary Disease Foundation’s Scientific Advisory Board selects Prize recipients and determines research programming for fiscal approval by the Board of Directors.